Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A genome screen for multiple sclerosis in Italian families.
A telerehabilitation program by virtual reality-video games improves balance and postural control in multiple sclerosis patients.
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.
Don't stress about it!: Is stress management a disease-modifying therapy for multiple sclerosis?
Benign Multiple Sclerosis: Does it exist?
A phase II study of laquinimod in Crohn's disease.
The influence of HLA-DRB1*15 on motor cortical pathology in multiple sclerosis.
Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis.
Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
Targeting insulin-like growth factor 1 leads to amelioration of inflammatory demyelinating disease.
Laquinimod suppress antigen presentation in relapsing-remitting multiple sclerosis: in-vitro high-throughput gene expression study.
UW-SES: A new self-efficacy scale for people with disabilities.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Plasma Exchange in a Patient with Tumefactive, Corticosteroid-Resistant Multiple Sclerosis.
Early bilateral cystoid macular oedema secondary to fingolimod in multiple sclerosis.
Therapeutic effect of ghrelin in experimental autoimmune encephalomyelitis by inhibiting antigen-specific Th1/Th17 responses and inducing regulatory T cells.
Stabilization of rapidly worsening multiple sclerosis for 36 months in patients treated with interferon beta plus cyclophosphamide followed by interferon beta.
Effects of natalizumab treatment on the CSF proteome of multiple sclerosis patients.
A Randomized Placebo-Controlled, Crossover-Design Study of the Effects of Low Dose Naltrexone
[The influence of locomotor treatment using robotic body-weight-supported treadmill training on rehabilitation outcome of patients suffering from neurological disorders].
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis.
Neuromyelitis Optica Following Human Papillomavirus Vaccination.
Vitamin D and multiple sclerosis: a critical review and recommendations on treatment.
Vitamin A and systemic inflammation as protective factors in multiple sclerosis.

Pages